Market Scope’s first-edition “2026 Myopia Management Market Report” provides a data-driven view of one of ophthalmology’s fastest-growing segments, with a focus on the rising pediatric myopia population and the shift toward earlier intervention. It quantifies the total, addressable, and serviceable markets, with five-year forecasts and detailed analysis of treatment volumes, adoption trends, and competitive dynamics across key regions.
The report provides deep segmentation across all major treatment categories—including myopia control spectacles, soft contact lenses, orthokeratology, and low-dose atropine—alongside insights into combination therapies, treatment efficacy, reimbursement, and barriers to adoption. It also examines the underlying drivers shaping demand, from demographic and lifestyle trends to provider behavior and access to care.
Expanded coverage of diagnostic technologies, digital platforms, and emerging therapies paired with global market analysis and company profiles gives you a complete picture of where the market is today and where it’s headed.
This report provides a comprehensive analysis of the global myopia management market, examining the underlying disease dynamics, patient populations, treatment approaches, and competitive landscape shaping this rapidly expanding segment. The study combines detailed market sizing with five-year forecasts across Market Scope’s eight global regions, along with in-depth evaluation of provider behavior, treatment adoption, and the factors driving growth—particularly within the pediatric population.
Coverage includes:
2 licensing types are available for this report:
Both licenses include an electronic PDF. Printed copies may be purchased for an additional $250.
SINGLE USER LICENSE
ENTERPRISE LICENSE
Pay by credit card or by invoice.
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.